The UK Bribery Act has broad scope and will affect anyone doing business with the UK, and Asian companies need to assess their corruption-related risks, according to AlixPartners' Rob Morris.
The medical equipment maker is the second Chinese medical play to tap the Hong Kong market this month, testing investor confidence in the country's healthcare reforms.